DNASE1L3 Mutations in Hypocomplementemic Urticarial Vasculitis Syndrome

Objective Hypocomplementemic urticarial vasculitis syndrome (HUVS) is characterized by recurrent urticaria along with dermal vasculitis, arthritis, and glomerulonephritis. Systemic lupus erythematosus (SLE) develops in >50% of patients with HUVS, although the pathogenesis is unknown. The aim of t...

Full description

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 65; no. 8; pp. 2183 - 2189
Main Authors Özçakar, Z. Birsin, Foster, Joseph, Diaz‐Horta, Oscar, Kasapcopur, Ozgur, Fan, Yao‐Shan, Yalçınkaya, Fatoş, Tekin, Mustafa
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective Hypocomplementemic urticarial vasculitis syndrome (HUVS) is characterized by recurrent urticaria along with dermal vasculitis, arthritis, and glomerulonephritis. Systemic lupus erythematosus (SLE) develops in >50% of patients with HUVS, although the pathogenesis is unknown. The aim of this study was to identify the causative DNA mutations in 2 families with autosomal‐recessive HUVS, in order to reveal the pathogenesis and facilitate the laboratory diagnosis. Methods Autozygosity mapping was combined with whole‐exome sequencing. Results In a family with 3 affected children, we identified a homozygous frameshift mutation, c.289_290delAC, in DNASE1L3. We subsequently identified another homozygous DNASE1L3 mutation leading to exon skipping, c.320+4delAGTA, in an unrelated family. The detected mutations led to loss of function, via either nonsense‐mediated messenger RNA decay or abolished endonuclease activity, as demonstrated by a plasmid nicking assay. Conclusion These results show that HUVS is caused by mutations in DNASE1L3, encoding an endonuclease that previously has been associated with SLE.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0004-3591
2326-5191
1529-0131
2326-5205
DOI:10.1002/art.38010